Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B5PU
|
||||
Former ID |
DNC004515
|
||||
Drug Name |
BMS-193884
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pulmonary arterial hypertension [ICD9: 416; ICD10:I27.0, I27.2] | Discontinued in Phase 2 | [546390] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H17N3O4S
|
||||
Canonical SMILES |
CC1=C(ON=C1C)NS(=O)(=O)C2=CC=CC=C2C3=CC=C(C=C3)C4=NC=CO<br />4
|
||||
InChI |
1S/C20H17N3O4S/c1-13-14(2)22-27-19(13)23-28(24,25)18-6-4-3-5-17(18)15-7-9-16(10-8-15)20-21-11-12-26-20/h3-12,23H,1-2H3
|
||||
InChIKey |
LJGUZUROJOJEMI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Endothelin-1 receptor | Target Info | Modulator | ||
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Endothelin signaling pathway | ||||
Pathway Interaction Database | Endothelins | ||||
EGFR-dependent Endothelin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.